Acrostak (Schweiz) AG - Company Review
Acrostak (Schweiz) AG - Company ReviewSummary
Acrostak (Schweiz) AG (Acrostak) is a medical device company that develops, manufactures, and distributes single use medical equipment. The company markets medical devices in the field of interventional cardiology. Its interventional cardiology products include across cpt st, a short tip and ultra low profile, which offer back-up support to guide wire; across cto, an angioplasty balloon for chronic total occluded lesions; and across hp, a high pressure ptca balloon. Acrostak also offers GRIP, a full control over slippery and calcified lesions; and GENIE, a local drug delivery catheter for anti-stenosis drug. The company provides medical devices to treat coronary diseases. It operates through manufacturing facility located in Winterthur. Acrostak is headquartered in Winterthur, Switzerland.
This comprehensive company report of Acrostak (Schweiz) AG provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.